The HIV community will soon get to look at data from the PURPOSE 1 clinical trial of twice-yearly lenacapavir for preexposure prophylaxis after interim results showed it was 100% effective in ...
Jared Baeten, MD, PhD, discusses when lenacapavir could be available for the prevention of HIV, as well as other trials in the PURPOSE program. The PURPOSE 1 [NCT04994509] results are, as I said ...
A person’s sense of purpose declines leading up to and following a diagnosis of dementia or cognitive decline, according to a new study. “Purpose in life is the feeling that one’s life is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback